In another study of MPNST, ATRX loss detected by immunohistochemistry was associated with worse overall survival; although, the group included partial or “mosaic” loss, which is not always associated with ATRX mutations and ALT [38]. This evidence concerns the gene ATRX and malignant peripheral nerve sheath tumor.